HGF, sIL-6R and TGF-β1 Play a Significant Role in the Progression of Multiple Myeloma.
Ontology highlight
ABSTRACT: Background. In the last few years, it has been widely reported that proinflammatory and angiogenic cytokines are important for the development and progression of multiple myeloma (MM). Objectives. To further validate and acquire more insight into this view we decided to check whether plasma levels of certain cytokines and their soluble receptors differ between MM patients and healthy subjects. Patients and Methods. The study was conducted in 76 MM patients aged 22 to 77 years (60±10 years) and 35 healthy controls aged 20 to 63 years (33±10 years). Plasma levels of interleukin-6 (IL-6), b-fibroblast growth factor (b-FGF), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and transforming growth factor-β1 (TGF-β1), as well as soluble receptors for IL-6 (sIL-6R) and VE
SUBMITTER: Jurczyszyn A
PROVIDER: S-EPMC4067511 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA